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was identifi ed in 1 sample. These 
results enabled us to compare DHPS 
genotypes for 6 pairs of samples. A 
full match was found for these 6 pairs. 
DHPS and ITS genotype matches 
were found for 4 pairs.
Several lines of evidence 
suggest that P. jirovecii is exhaled 
by infected patients and transmitted 
by the airborne route to susceptible 
persons (4). In the study reported 
here, ITS or DHPS genotype matches 
between pairs of pulmonary and 
air samples are consistent with the 
possibility that P. jirovecii organisms 
in the air originated from patients. 
DHPS mutants were detected in 6 
(40%) of the 15 pulmonary samples; 
none of the15 patients had received 
sulfonamide treatment at the time of 
PCP diagnosis. These results were 
not unexpected because frequency of 
fi nding DHPS mutants in PCP patients 
in Paris who had no prior sulfonamide 
treatment is high (8). The exhalation of 
DHPS mutants from infected patients 
can spread potentially sulfonamide-
resistant organisms.
Matches of P. jirovecii genotypes 
in pairs of pulmonary and room air 
samples argue in favor of P. jirovecii 
exhalation by infected patients. The 
exhalation of P. jirovecii organisms 
emphasizes the risk for their 
nosocomial transmission. Our data 
provide additional arguments in favor 
of the application of measures to 
prevent the airborne transmission of P. 
jirovecii in hospitals.
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and Dengue Virus, 
Puerto Rico, 2010
To the Editor: Leptospirosis, 
caused by Leptospira spp. bacteria, 
and dengue, caused by dengue viruses 
(DENVs), are potentially fatal acute 
febrile illnesses (AFI) endemic 
to the tropics (1,2). Because their 
clinical manifestations are similar (3), 
leptospirosis may be misidentifi ed as 
dengue (4). We report a fatal case of 
co-infection with Leptospira spp. and 
DENV-1 in a man in Puerto Rico.
On May 23, 2010, a 42-year-old 
unemployed male carpenter came to 
an outpatient clinic in Puerto Rico 
reporting a 4-day history of fever, 
headache, generalized myalgia, 
anorexia, nausea, and vomiting. He was 
being treated for chronic hypertension 
and had been released from jail 2 weeks 
before illness onset. On evaluation, 
he was febrile, hypertensive, and 
tachycardic; laboratory results showed 
thrombocytopenia and leukocytosis 
with a predominance of neutrophils. 
Viral syndrome was diagnosed, and 
the patient was given acetaminophen, 
solumedrol, and ketoprofen.
The patient returned to the clinic on 
May 25 with continued fever, myalgia, 
worsening headache, and bilateral calf 
pain; he was afebrile and tachycardic 
and appeared acutely ill. He had no 
rash, jaundice, icteric sclera, cardiac 
murmurs, or organomegaly, and his 
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lungs were clear on auscultation. 
He was given intravenous (IV) 
saline, and results of laboratory 
tests performed afterward showed 
leukocytosis with a predominance 
of neutrophils, thrombocytopenia, 
increased blood urea nitrogen (BUN)–
to-creatinine ratio, hyponatremia, 
hyperglycemia, and elevated aspartate 
aminotransferase. He was given 
IV ampicillin, meperidine, and 
promethazine and was transferred to 
a local hospital for admission, with 
a presumptive diagnosis of pre–renal 
azotemia and leptospirosis.
On arrival at the emergency 
department on the same day, the 
patient was febrile, tachycardic, and 
hypotensive, with cold, clammy skin. 
Results of an electrocardiogram showed 
sinus tachycardia; cardiac enzymes 
were not elevated. He was given repeat 
IV saline and piperacillin/tazobactam. 
New laboratory fi ndings included 
anemia, prolonged prothrombin time, 
elevated creatinine kinase, hematuria, 
and a further increase in BUN-to-
creatine ratio. Chest radiograph 
showed cardiomegaly with increased 
pulmonary vascularity and perihilar 
alveolar densities. Arterial blood gas 
(ABG) results showed compensated 
metabolic acidosis, with low oxygen 
partial pressure (pO2). He was given 
IV saline again, and vancomycin 
and ceftriaxone were added to his 
medication regimen.
On admission to the intensive 
care unit, the patient continued to be 
hypotensive and was again given IV 
saline. Although ABG results on the 
morning of May 26 were somewhat 
improved, the patient was started on 
respiratory treatments for new-onset 
cough and increasing respiratory 
rate. Laboratory test results showed 
a large drop in hematocrit, worsening 
thrombocytopenia and leukocytosis, 
hypocalcemia, and hypoalbuminemia; 
he was given an infusion of 25% 
albumin.
The patient’s condition continued 
to worsen, with ABG results showing 
further decline in pO2. Severe 
respiratory distress developed, and he 
was placed on mechanical ventilation 
and given IV saline. Repeat ABG 
results showed severe respiratory 
acidosis and metabolic acidosis. Soon 
after, generalized edema developed, 
and the patient became cyanotic, 
with no measurable pulse; despite 
aggressive resuscitation efforts, he 
died on March 26.
All results of bacterial cultures 
were negative, as was detection of 
anti-Leptospira IgM. Postmortem 
examination showed rash and pleural 
effusion, and blood and tissue 
specimens were taken for diagnostic 
testing. Liver sections showed bile 
stasis, dilated sinusoidal space, and 
pericentral hepatocellular necrosis 
(Figure, panel A); lung sections 
showed intraalveolar hemorrhage, 
edema, and focal infl ammatory 
infi ltrates (Figure, panel B). Heart 
sections showed perivascular edema, 
and kidney sections showed evidence 
of interstitial infl ammatory infi ltrates 
and acute tubular necrosis (Figure, 
panel C). Immunohistochemical ana-
lysis of kidney (Figure, panel D), 
liver, lung, and heart sections showed 
Leptospira antigen. Dengue virus 
nonstructural (NS) protein 1 was 
detected in whole blood, and fl avivirus 
NS5 gene was amplifi ed from RNA 
extracted from the liver; sequencing 
showed 98% homology with DENV-1.
This case report demonstrates 
the need for antigen-based rapid 
diagnostic tests (RDT) for AFI 
patients. All available leptospirosis 
RDTs detect anti-Leptospira IgM 
(5), which was not detectable in this 
patient’s blood on the seventh day of 
illness, although Leptospira antigen 
was detected in postmortem analysis. 
Therefore, it is unlikely that any 
available leptospirosis RDT would 
have been clinically useful when 
leptospirosis signs fi rst were recorded 
on the fourth day of illness. Because 
the incidence of both dengue and 
leptospirosis is increasing worldwide 
(6,7), physicians should have access 
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Figure. Histopathologic evaluation of tissue samples collected postmortem from a person 
co-infected with Leptospira spp. and dengue virus 1. Tissue specimens were taken from 
the liver (A), lung (B) and kidney (C and D) and stained with hemotoxylin-eosin (A, B, 
C; original magnifi cation ×20) or probed with polyclonal anti-Leptospira antibody for 
immunohistochemical detection of Leptospira antigen (D; arrowheads indicate antigen; 
original magnifi cation ×63). A color fi gure of this fi gure is available online (wwwnc.cdc.gov/
EID/article/18/5/11-1555-F1.htm).
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to antigen-based RDT to make timely 
and thorough diagnoses.
Nonetheless, even if leptospirosis 
had been diagnosed in this patient, 
dengue virus infection would 
likely still have been overlooked.
Therefore, clinicians in areas where 
both Leptospira spp. and DENVs 
are endemic should include both 
pathogens in the differential diagnosis 
when evaluating AFI patients and 
should consider the possibility of 
co-infection. Early administration 
of doxycycline and penicillin G to 
treat mild and severe leptospirosis, 
respectively, may reduce the duration 
and severity of illness (8). For cases 
of severe dengue, packed red blood 
cells should be given in response to 
severe anemia. For patients with either 
dengue or leptospirosis, intravenous 
fl uid administration should be closely 
monitored to prevent fl uid overload.
Tyler M. Sharp, Julio Bracero, 





Sherif R. Zaki, 
and Kay M. Tomashek
Author affi liations: Centers for Disease 
Control and Prevention, Atlanta, Georgia, 
USA (T.M. Sharp, W.-J. Shieh, J. Bhatnagar, 
S.R. Zaki); Centers For Disease Control 
and Prevention, San Juan, Puerto Rico 
(T.M. Sharp, A. Rivera, E. Hunsperger, J. 
Munoz-Jordan, K.M. Tomashek); Hospital 
Episcopal San Lucas, Ponce, Puerto Rico 
(J. Barcero); and Instituto de Ciencias 




  1.  Koppisch ER, Suerez RN, Hohlschutter 
E, Hernandez-Moralez F. Weil’s disease 
in Puerto Rico: report of fi ve cases, one 
of them with post-mortem fi ndings. PR J 
Public Health Trop Med. 1942;17:305–31.
  2.  Bruce MG, Sanders EJ, Leake JA, 
Zaidel O, Bragg SL, Aye T, et al. Lep-
tospirosis among patients presenting 
with dengue-like illness in Puerto Rico. 
Acta Trop. 2005;96:36–46. http://dx.doi.
org/10.1016/j.actatropica.2005.07.001
  3.  Libraty DH, Myint KS, Murray CK, Gib-
bons RV, Mammen MP, Endy TP, et al. 
A comparative study of leptospirosis 
and dengue in Thai children. PLoS Negl 
Trop Dis. 2007;1:e111. http://dx.doi.
org/10.1371/journal.pntd.0000111
  4.  Ellis T, Imrie A, Katz AR, Effl er PV. 
Underrecognition of leptospirosis dur-
ing a dengue fever outbreak in Hawaii, 
2001–2002. Vector Borne Zoonotic Dis. 
2008;8:541–7. http://dx.doi.org/10.1089/
vbz.2007.0241
  5.  Bajani MD, Ashford DA, Bragg SL, 
Woods CW, Aye T, Spiegel RA, et al. 
Evaluation of four commercially available 
rapid serologic tests for diagnosis of lepto-
spirosis. J Clin Microbiol. 2003;41:803–9. 
http://dx.doi.org/10.1128/JCM.41.2.803-
809.2003
  6.  Gubler DJ. Dengue/dengue haemorrhagic 
fever: history and current status. Novartis 
Found Symp. 2006;277:3–16; discussion 
16–22, 71–3, 251–3.
  7.  Hartskeerl RA, Collares-Pereira M, Ellis 
WA. Emergence, control and re-emerg-
ing leptospirosis: dynamics of infection 
in the changing world. Clin Microbiol 
Infect. 2011;17:494–501. http://dx.doi.
org/10.1111/j.1469-0691.2011.03474.x
  8.  Bharti AR, Nally JE, Ricaldi JN, Mat-
thias MA, Diaz MM, Lovett MA, et 
al. Leptospirosis: a zoonotic disease of 
global importance. Lancet Infect Dis. 
2003;3:757–71. http://dx.doi.org/10.1016/
S1473-3099(03)00830-2
Address for correspondence: Kay M. Tomashek, 
Centers for Disease Control and Prevention, 
1324 Calle Cañada, San Juan 00920-3860, 
Puerto Rico; email: kct9@cdc.gov
Serologic Evidence 
of West Nile Virus 
Infection among 
Humans, Morocco
To the Editor: West Nile virus 
(WNV) infections were reported in 
horses in Morocco in 1996, 2003 
(1), and 2010 (2). The isolates from 
1996 and 2003 belong to WNV 
lineage 1, clade 1a (1). In 1996, 
WNV infection was reported in a 
human in Morocco (3), and in 2008, 
a serosurvey of wild birds confi rmed 
the circulation of WNV in native 
birds (4). To our knowledge, there 
are no seroprevalence data for WNV 
antibodies in humans in Morocco. 
Thus, we evaluated the prevalence of 
WNV neutralizing bodies in serum 
samples collected during March–April 
2011 from 499 healthy persons living 
in the vicinities of Meknes, Rabat, 
or Kenitra. All persons consented to 
study participation.
The participants were divided 
into 3 cohorts, A, B, and C. Cohort 
A consisted of 150 persons from 
the Meknes area, where no WNV 
infections among horses have been 
reported. The mean age of persons 
in cohort A was 52 years (SD ± 15 
years), and 31% were male. Cohort B 
consisted of 200 persons living in the 
region of Rabat (median age 49 years 
[SD ± 12 years]; 38% male), where the 
WNV outbreaks among horses were 
described in 1996 (3) and 2010 (2). 
Cohort C consisted of 149 participants 
living in the region of Kenitra (median 
age 48 years [SD ± 17 years]; 43% 
male), which was affected by the 
WNV outbreaks among horses in 
1996, 2003, and 2010.
Serum was stored at −20°C until 
tested. Just before testing, serum 
samples were heated at 56°C for 30 
minutes. The samples were screened 
for neutralizing antibody against 
the equine WNV strain, Morocco 
96–111 (3), by using a micro virus-
neutralization test in 96-well plates and 
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